C07H 7/06
Heterocyclic radicals
C07H7/06 (Heterocyclic radicals) appears on 135 US grants and 178 published applications in this corpus.
Search patents in C07H- Granted patents
- 135
- Published applications
- 178
- Assignees
- 126
- Inventors
- 456
- Latest grant
- 1 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 2 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 2 | 0 |
| 2002 | 4 | 5 |
| 2003 | 3 | 1 |
| 2004 | 0 | 1 |
| 2005 | 2 | 2 |
| 2006 | 1 | 9 |
| 2007 | 0 | 2 |
| 2008 | 3 | 5 |
| 2009 | 4 | 3 |
| 2010 | 5 | 7 |
| 2011 | 7 | 8 |
| 2012 | 3 | 6 |
| 2013 | 6 | 6 |
| 2014 | 2 | 7 |
| 2015 | 4 | 9 |
| 2016 | 5 | 7 |
| 2017 | 5 | 7 |
| 2018 | 9 | 9 |
| 2019 | 6 | 9 |
| 2020 | 8 | 9 |
| 2021 | 8 | 13 |
| 2022 | 8 | 7 |
| 2023 | 12 | 16 |
| 2024 | 5 | 14 |
| 2025 | 7 | 9 |
| 2026 | 5 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Antiviral compounds and methods of making and using the same1 Sep 2026US 12,723,057 B2Gilead Sciences, Inc.
- Catalysts and their uses in one-pot diastereoselective synthesis of remdesivir30 Jun 2026US 12,667,832 B2Academia Sinica
- Promoiety strategy to enhance drug activity12 May 2026US 12,624,058 B2University of Southern California
- Antiviral prodrugs, intermediate-and long-acting formulations and methods7 Apr 2026US 12,594,292 B2The Regents of the University of California
- Remdesivir and remdesivir analogs, solutions, and nanoparticle, liposomal, and microparticle compositions for treating viral infections6 Jan 2026US 12,516,080 B2The Regents of the University of Michigan
- Method for purifying chrysomycin a from fermentation products of streptomyces8 Oct 2026US 2026/0308195 A1Zhejiang University of Technology
- Sodium -glucose contransporter 2 inhibitor derivative6 Aug 2026US 2026/0226090 A1Anxo Pharmaceutical Co., Ltd.
- Antiviral prodrugs, intermediate-and long-acting formulations and methods4 Jun 2026US 2026/0151415 A1The Regents of the University of California
- Methods and compositions for inhibition of polymerase21 May 2026US 2026/0137688 A1Island Pharmaceuticals, Ltd.
- Contrast agents for enhanced magnetic resonance imaging2 Apr 2026US 2026/0091145 A1San Jose State University Research Foundation
Most cited
By later US patents
- 2'-fluoro substituted carba-nucleoside analogs for antiviral treatment116US 7,973,013 B2Gilead Sciences, Inc. · 2011
- Fluorescent nucleoside analogs and combinatorial fluorophore arrays comprising same84US 6,479,650 B1Research Corporation Technologies, Inc. · 2002
- Therapeutic furopyrimidines and thienopyrimidines78US 7,429,571 B2BioCryst Pharmaceuticals, Inc. · 2008
- Hepatitis C therapies75US 7,514,410 B2BioCryst Pharmaceuticals, Inc. · 2009
- Fluorescent nucleoside analogs and combinatorial fluorophore arrays comprising same53US 6,670,193 B2Research Corporation Technologies, Inc. · 2003